Global Antibody Testing Market

Antibody Testing Comprehensive Study by Type (Assay Kits & Reagents, Software & Services), Application (Hospitals, Clinical Laboratories, Test Centers), Disease (Covid-19, Human Immunodeficiency Virus (HIV), Crest Syndrome, Other), Technique (Inova Diagnostics (United States), Zeus Scientific Inc. (United States), Ortho Clinical Diagnostics (Unites States)) Players and Region - Global Market Outlook to 2028

Antibody Testing Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Antibody Testing Market Scope
Antibodies are immunoglobulins, which are Y-shaped proteins formed by the immune system to help protect the body from foreign invaders. An antibody test is a blood test that tests for the existence of antibodies. When the body battles an infection, such as COVID-19, or when patients undergo a vaccine, such as a flu shot, antibodies are formed. Which is how a virus's immunity is created. These tests are also known as serology tests. After the illness has passed, these checks are deployed to assess the incidence of disease in a population. Serology examinations include blood samples, which are obtained from a person's arm or a finger stick. Prevalence of Covid and SARS cases are major factors owing to growth in Antibody Testing market.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledAlere Inc. (United States), Hoffmann La Roche, Abbott Laboratories, Bio-Rad Laboratories Inc. (United States), ERBA Diagnostics Inc. (United States), Trinity Biotech plc (Ireland), Thermo Fisher Scientific Inc. (United States), Antibodies Inc. (United States), EUROIMMUN AG (Germany) and Immuno Concepts (United States)
CAGR%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Antibody Testing market throughout the predicted period.

Alere Inc. (United States), Hoffmann La Roche, Abbott Laboratories, Bio-Rad Laboratories Inc. (United States), ERBA Diagnostics Inc. (United States), Trinity Biotech plc (Ireland), Thermo Fisher Scientific Inc. (United States), Antibodies Inc. (United States), EUROIMMUN AG (Germany) and Immuno Concepts (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Inova Diagnostics (United States), Zeus Scientific Inc. (United States) and Ortho Clinical Diagnostics (Unites States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Antibody Testing market by Type , by Application (Hospitals, Clinical Laboratories and Test Centers) and Region with country level break-up.

On the basis of geography, the market of Antibody Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
On 22nd June, 2020 - Abbott Reported Today That It Has Started Shipping Its Laboratory-Based Serology Blood Test for Detecting the Antibody Igg (Immunoglobulin G), The Supply Contract Includes Over A Million Test Kits for IgG Lab-Based Antibody Tests to India.
On 18th August, 2020 - Trinity Biotech (Leading Diagnostics Developer & Manufacturer), has obtained an Emergency Use Authorization (EUA) from the US Food and Drug Administration for its Covid-19 IgG ELISA Antibody Test.
United States, Food and Drug Administration “Information on the Use of Serological (Antibody) Tests” – Provides A Comprehensive List of Guidelines Which Restrict the Use of Serological (Antibody) Tests to Diagnose COVID-19; Instead, They Can Be Used to Determine If an Individual Has Been Exposed. and European Union, MDCG Regulation (EU) 2017/745 “Guidance on state of the art of COVID-19 rapid antibody tests” - Defines Certain Instruments Must Meet the Manufacturer's Specified Performance Requirements, Including Analytical Sensitivity, Diagnostic Precision, Analytical Specificity, Diagnostic Specificity, Precision, Repeatability, Reproducibility, Monitoring of Identified Related Interference, and Detection Limits.

Influencing Trend:
Technical Progress in Medical Industry and Heavy Investments in Research & Development

Market Growth Drivers:
Prevalence of SARS-CoV-2 Cases and Emergence of Advance and Effective Techniques

Challenges:
Sudden Demand Shocks Such as Due to Covid-19

Restraints:
Does Not Detect Virus

Opportunities:
Low Penetration in Remote Regions

Key Target Audience
Antibody Test Manufactures, New Entrants and Investors, Antibody Test Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Assay Kits & Reagents
  • Software & Services
By Application
  • Hospitals
  • Clinical Laboratories
  • Test Centers
By Disease
  • Covid-19
  • Human Immunodeficiency Virus (HIV)
  • Crest Syndrome
  • Other

By Technique
  • Inova Diagnostics (United States)
  • Zeus Scientific Inc. (United States)
  • Ortho Clinical Diagnostics (Unites States)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of SARS-CoV-2 Cases
      • 3.2.2. Emergence of Advance and Effective Techniques
    • 3.3. Market Challenges
      • 3.3.1. Sudden Demand Shocks Such as Due to Covid-19
    • 3.4. Market Trends
      • 3.4.1. Technical Progress in Medical Industry
      • 3.4.2. Heavy Investments in Research & Development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antibody Testing, by Type, Application, Disease, Technique and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Antibody Testing (Value)
      • 5.2.1. Global Antibody Testing by: Type (Value)
        • 5.2.1.1. Assay Kits & Reagents
        • 5.2.1.2. Software & Services
      • 5.2.2. Global Antibody Testing by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinical Laboratories
        • 5.2.2.3. Test Centers
      • 5.2.3. Global Antibody Testing by: Disease (Value)
        • 5.2.3.1. Covid-19
        • 5.2.3.2. Human Immunodeficiency Virus (HIV)
        • 5.2.3.3. Crest Syndrome
        • 5.2.3.4. Other
      • 5.2.4. Global Antibody Testing by: Technique (Value)
        • 5.2.4.1. Inova Diagnostics (United States)
        • 5.2.4.2. Zeus Scientific Inc. (United States)
        • 5.2.4.3. Ortho Clinical Diagnostics (Unites States)
      • 5.2.5. Global Antibody Testing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Antibody Testing (Volume)
      • 5.3.1. Global Antibody Testing by: Type (Volume)
        • 5.3.1.1. Assay Kits & Reagents
        • 5.3.1.2. Software & Services
      • 5.3.2. Global Antibody Testing by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinical Laboratories
        • 5.3.2.3. Test Centers
      • 5.3.3. Global Antibody Testing by: Disease (Volume)
        • 5.3.3.1. Covid-19
        • 5.3.3.2. Human Immunodeficiency Virus (HIV)
        • 5.3.3.3. Crest Syndrome
        • 5.3.3.4. Other
      • 5.3.4. Global Antibody Testing by: Technique (Volume)
        • 5.3.4.1. Inova Diagnostics (United States)
        • 5.3.4.2. Zeus Scientific Inc. (United States)
        • 5.3.4.3. Ortho Clinical Diagnostics (Unites States)
      • 5.3.5. Global Antibody Testing Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Antibody Testing (Price)
      • 5.4.1. Global Antibody Testing by: Type (Price)
  • 6. Antibody Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alere Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hoffmann La Roche
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bio-Rad Laboratories Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ERBA Diagnostics Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Trinity Biotech plc (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Thermo Fisher Scientific Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Antibodies Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. EUROIMMUN AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Immuno Concepts (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Antibody Testing Sale, by Type, Application, Disease, Technique and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Antibody Testing (Value)
      • 7.2.1. Global Antibody Testing by: Type (Value)
        • 7.2.1.1. Assay Kits & Reagents
        • 7.2.1.2. Software & Services
      • 7.2.2. Global Antibody Testing by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinical Laboratories
        • 7.2.2.3. Test Centers
      • 7.2.3. Global Antibody Testing by: Disease (Value)
        • 7.2.3.1. Covid-19
        • 7.2.3.2. Human Immunodeficiency Virus (HIV)
        • 7.2.3.3. Crest Syndrome
        • 7.2.3.4. Other
      • 7.2.4. Global Antibody Testing by: Technique (Value)
        • 7.2.4.1. Inova Diagnostics (United States)
        • 7.2.4.2. Zeus Scientific Inc. (United States)
        • 7.2.4.3. Ortho Clinical Diagnostics (Unites States)
      • 7.2.5. Global Antibody Testing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Antibody Testing (Volume)
      • 7.3.1. Global Antibody Testing by: Type (Volume)
        • 7.3.1.1. Assay Kits & Reagents
        • 7.3.1.2. Software & Services
      • 7.3.2. Global Antibody Testing by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinical Laboratories
        • 7.3.2.3. Test Centers
      • 7.3.3. Global Antibody Testing by: Disease (Volume)
        • 7.3.3.1. Covid-19
        • 7.3.3.2. Human Immunodeficiency Virus (HIV)
        • 7.3.3.3. Crest Syndrome
        • 7.3.3.4. Other
      • 7.3.4. Global Antibody Testing by: Technique (Volume)
        • 7.3.4.1. Inova Diagnostics (United States)
        • 7.3.4.2. Zeus Scientific Inc. (United States)
        • 7.3.4.3. Ortho Clinical Diagnostics (Unites States)
      • 7.3.5. Global Antibody Testing Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Antibody Testing (Price)
      • 7.4.1. Global Antibody Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antibody Testing: by Type(USD Million)
  • Table 2. Antibody Testing Assay Kits & Reagents , by Region USD Million (2017-2022)
  • Table 3. Antibody Testing Software & Services , by Region USD Million (2017-2022)
  • Table 4. Antibody Testing: by Application(USD Million)
  • Table 5. Antibody Testing Hospitals , by Region USD Million (2017-2022)
  • Table 6. Antibody Testing Clinical Laboratories , by Region USD Million (2017-2022)
  • Table 7. Antibody Testing Test Centers , by Region USD Million (2017-2022)
  • Table 8. Antibody Testing: by Disease(USD Million)
  • Table 9. Antibody Testing Covid-19 , by Region USD Million (2017-2022)
  • Table 10. Antibody Testing Human Immunodeficiency Virus (HIV) , by Region USD Million (2017-2022)
  • Table 11. Antibody Testing Crest Syndrome , by Region USD Million (2017-2022)
  • Table 12. Antibody Testing Other , by Region USD Million (2017-2022)
  • Table 13. Antibody Testing: by Technique(USD Million)
  • Table 14. Antibody Testing Inova Diagnostics (United States) , by Region USD Million (2017-2022)
  • Table 15. Antibody Testing Zeus Scientific Inc. (United States) , by Region USD Million (2017-2022)
  • Table 16. Antibody Testing Ortho Clinical Diagnostics (Unites States) , by Region USD Million (2017-2022)
  • Table 17. South America Antibody Testing, by Country USD Million (2017-2022)
  • Table 18. South America Antibody Testing, by Type USD Million (2017-2022)
  • Table 19. South America Antibody Testing, by Application USD Million (2017-2022)
  • Table 20. South America Antibody Testing, by Disease USD Million (2017-2022)
  • Table 21. South America Antibody Testing, by Technique USD Million (2017-2022)
  • Table 22. Brazil Antibody Testing, by Type USD Million (2017-2022)
  • Table 23. Brazil Antibody Testing, by Application USD Million (2017-2022)
  • Table 24. Brazil Antibody Testing, by Disease USD Million (2017-2022)
  • Table 25. Brazil Antibody Testing, by Technique USD Million (2017-2022)
  • Table 26. Argentina Antibody Testing, by Type USD Million (2017-2022)
  • Table 27. Argentina Antibody Testing, by Application USD Million (2017-2022)
  • Table 28. Argentina Antibody Testing, by Disease USD Million (2017-2022)
  • Table 29. Argentina Antibody Testing, by Technique USD Million (2017-2022)
  • Table 30. Rest of South America Antibody Testing, by Type USD Million (2017-2022)
  • Table 31. Rest of South America Antibody Testing, by Application USD Million (2017-2022)
  • Table 32. Rest of South America Antibody Testing, by Disease USD Million (2017-2022)
  • Table 33. Rest of South America Antibody Testing, by Technique USD Million (2017-2022)
  • Table 34. Asia Pacific Antibody Testing, by Country USD Million (2017-2022)
  • Table 35. Asia Pacific Antibody Testing, by Type USD Million (2017-2022)
  • Table 36. Asia Pacific Antibody Testing, by Application USD Million (2017-2022)
  • Table 37. Asia Pacific Antibody Testing, by Disease USD Million (2017-2022)
  • Table 38. Asia Pacific Antibody Testing, by Technique USD Million (2017-2022)
  • Table 39. China Antibody Testing, by Type USD Million (2017-2022)
  • Table 40. China Antibody Testing, by Application USD Million (2017-2022)
  • Table 41. China Antibody Testing, by Disease USD Million (2017-2022)
  • Table 42. China Antibody Testing, by Technique USD Million (2017-2022)
  • Table 43. Japan Antibody Testing, by Type USD Million (2017-2022)
  • Table 44. Japan Antibody Testing, by Application USD Million (2017-2022)
  • Table 45. Japan Antibody Testing, by Disease USD Million (2017-2022)
  • Table 46. Japan Antibody Testing, by Technique USD Million (2017-2022)
  • Table 47. India Antibody Testing, by Type USD Million (2017-2022)
  • Table 48. India Antibody Testing, by Application USD Million (2017-2022)
  • Table 49. India Antibody Testing, by Disease USD Million (2017-2022)
  • Table 50. India Antibody Testing, by Technique USD Million (2017-2022)
  • Table 51. South Korea Antibody Testing, by Type USD Million (2017-2022)
  • Table 52. South Korea Antibody Testing, by Application USD Million (2017-2022)
  • Table 53. South Korea Antibody Testing, by Disease USD Million (2017-2022)
  • Table 54. South Korea Antibody Testing, by Technique USD Million (2017-2022)
  • Table 55. Taiwan Antibody Testing, by Type USD Million (2017-2022)
  • Table 56. Taiwan Antibody Testing, by Application USD Million (2017-2022)
  • Table 57. Taiwan Antibody Testing, by Disease USD Million (2017-2022)
  • Table 58. Taiwan Antibody Testing, by Technique USD Million (2017-2022)
  • Table 59. Australia Antibody Testing, by Type USD Million (2017-2022)
  • Table 60. Australia Antibody Testing, by Application USD Million (2017-2022)
  • Table 61. Australia Antibody Testing, by Disease USD Million (2017-2022)
  • Table 62. Australia Antibody Testing, by Technique USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Antibody Testing, by Type USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Antibody Testing, by Application USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Antibody Testing, by Disease USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Antibody Testing, by Technique USD Million (2017-2022)
  • Table 67. Europe Antibody Testing, by Country USD Million (2017-2022)
  • Table 68. Europe Antibody Testing, by Type USD Million (2017-2022)
  • Table 69. Europe Antibody Testing, by Application USD Million (2017-2022)
  • Table 70. Europe Antibody Testing, by Disease USD Million (2017-2022)
  • Table 71. Europe Antibody Testing, by Technique USD Million (2017-2022)
  • Table 72. Germany Antibody Testing, by Type USD Million (2017-2022)
  • Table 73. Germany Antibody Testing, by Application USD Million (2017-2022)
  • Table 74. Germany Antibody Testing, by Disease USD Million (2017-2022)
  • Table 75. Germany Antibody Testing, by Technique USD Million (2017-2022)
  • Table 76. France Antibody Testing, by Type USD Million (2017-2022)
  • Table 77. France Antibody Testing, by Application USD Million (2017-2022)
  • Table 78. France Antibody Testing, by Disease USD Million (2017-2022)
  • Table 79. France Antibody Testing, by Technique USD Million (2017-2022)
  • Table 80. Italy Antibody Testing, by Type USD Million (2017-2022)
  • Table 81. Italy Antibody Testing, by Application USD Million (2017-2022)
  • Table 82. Italy Antibody Testing, by Disease USD Million (2017-2022)
  • Table 83. Italy Antibody Testing, by Technique USD Million (2017-2022)
  • Table 84. United Kingdom Antibody Testing, by Type USD Million (2017-2022)
  • Table 85. United Kingdom Antibody Testing, by Application USD Million (2017-2022)
  • Table 86. United Kingdom Antibody Testing, by Disease USD Million (2017-2022)
  • Table 87. United Kingdom Antibody Testing, by Technique USD Million (2017-2022)
  • Table 88. Netherlands Antibody Testing, by Type USD Million (2017-2022)
  • Table 89. Netherlands Antibody Testing, by Application USD Million (2017-2022)
  • Table 90. Netherlands Antibody Testing, by Disease USD Million (2017-2022)
  • Table 91. Netherlands Antibody Testing, by Technique USD Million (2017-2022)
  • Table 92. Rest of Europe Antibody Testing, by Type USD Million (2017-2022)
  • Table 93. Rest of Europe Antibody Testing, by Application USD Million (2017-2022)
  • Table 94. Rest of Europe Antibody Testing, by Disease USD Million (2017-2022)
  • Table 95. Rest of Europe Antibody Testing, by Technique USD Million (2017-2022)
  • Table 96. MEA Antibody Testing, by Country USD Million (2017-2022)
  • Table 97. MEA Antibody Testing, by Type USD Million (2017-2022)
  • Table 98. MEA Antibody Testing, by Application USD Million (2017-2022)
  • Table 99. MEA Antibody Testing, by Disease USD Million (2017-2022)
  • Table 100. MEA Antibody Testing, by Technique USD Million (2017-2022)
  • Table 101. Middle East Antibody Testing, by Type USD Million (2017-2022)
  • Table 102. Middle East Antibody Testing, by Application USD Million (2017-2022)
  • Table 103. Middle East Antibody Testing, by Disease USD Million (2017-2022)
  • Table 104. Middle East Antibody Testing, by Technique USD Million (2017-2022)
  • Table 105. Africa Antibody Testing, by Type USD Million (2017-2022)
  • Table 106. Africa Antibody Testing, by Application USD Million (2017-2022)
  • Table 107. Africa Antibody Testing, by Disease USD Million (2017-2022)
  • Table 108. Africa Antibody Testing, by Technique USD Million (2017-2022)
  • Table 109. North America Antibody Testing, by Country USD Million (2017-2022)
  • Table 110. North America Antibody Testing, by Type USD Million (2017-2022)
  • Table 111. North America Antibody Testing, by Application USD Million (2017-2022)
  • Table 112. North America Antibody Testing, by Disease USD Million (2017-2022)
  • Table 113. North America Antibody Testing, by Technique USD Million (2017-2022)
  • Table 114. United States Antibody Testing, by Type USD Million (2017-2022)
  • Table 115. United States Antibody Testing, by Application USD Million (2017-2022)
  • Table 116. United States Antibody Testing, by Disease USD Million (2017-2022)
  • Table 117. United States Antibody Testing, by Technique USD Million (2017-2022)
  • Table 118. Canada Antibody Testing, by Type USD Million (2017-2022)
  • Table 119. Canada Antibody Testing, by Application USD Million (2017-2022)
  • Table 120. Canada Antibody Testing, by Disease USD Million (2017-2022)
  • Table 121. Canada Antibody Testing, by Technique USD Million (2017-2022)
  • Table 122. Mexico Antibody Testing, by Type USD Million (2017-2022)
  • Table 123. Mexico Antibody Testing, by Application USD Million (2017-2022)
  • Table 124. Mexico Antibody Testing, by Disease USD Million (2017-2022)
  • Table 125. Mexico Antibody Testing, by Technique USD Million (2017-2022)
  • Table 126. Antibody Testing Sales: by Type(K Unit)
  • Table 127. Antibody Testing Sales Assay Kits & Reagents , by Region K Unit (2017-2022)
  • Table 128. Antibody Testing Sales Software & Services , by Region K Unit (2017-2022)
  • Table 129. Antibody Testing Sales: by Application(K Unit)
  • Table 130. Antibody Testing Sales Hospitals , by Region K Unit (2017-2022)
  • Table 131. Antibody Testing Sales Clinical Laboratories , by Region K Unit (2017-2022)
  • Table 132. Antibody Testing Sales Test Centers , by Region K Unit (2017-2022)
  • Table 133. Antibody Testing Sales: by Disease(K Unit)
  • Table 134. Antibody Testing Sales Covid-19 , by Region K Unit (2017-2022)
  • Table 135. Antibody Testing Sales Human Immunodeficiency Virus (HIV) , by Region K Unit (2017-2022)
  • Table 136. Antibody Testing Sales Crest Syndrome , by Region K Unit (2017-2022)
  • Table 137. Antibody Testing Sales Other , by Region K Unit (2017-2022)
  • Table 138. Antibody Testing Sales: by Technique(K Unit)
  • Table 139. Antibody Testing Sales Inova Diagnostics (United States) , by Region K Unit (2017-2022)
  • Table 140. Antibody Testing Sales Zeus Scientific Inc. (United States) , by Region K Unit (2017-2022)
  • Table 141. Antibody Testing Sales Ortho Clinical Diagnostics (Unites States) , by Region K Unit (2017-2022)
  • Table 142. South America Antibody Testing Sales, by Country K Unit (2017-2022)
  • Table 143. South America Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 144. South America Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 145. South America Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 146. South America Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 147. Brazil Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 148. Brazil Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 149. Brazil Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 150. Brazil Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 151. Argentina Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 152. Argentina Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 153. Argentina Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 154. Argentina Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 155. Rest of South America Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 156. Rest of South America Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 157. Rest of South America Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 158. Rest of South America Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 159. Asia Pacific Antibody Testing Sales, by Country K Unit (2017-2022)
  • Table 160. Asia Pacific Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 161. Asia Pacific Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 162. Asia Pacific Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 163. Asia Pacific Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 164. China Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 165. China Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 166. China Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 167. China Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 168. Japan Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 169. Japan Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 170. Japan Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 171. Japan Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 172. India Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 173. India Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 174. India Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 175. India Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 176. South Korea Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 177. South Korea Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 178. South Korea Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 179. South Korea Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 180. Taiwan Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 181. Taiwan Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 182. Taiwan Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 183. Taiwan Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 184. Australia Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 185. Australia Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 186. Australia Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 187. Australia Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 188. Rest of Asia-Pacific Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 189. Rest of Asia-Pacific Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 190. Rest of Asia-Pacific Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 191. Rest of Asia-Pacific Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 192. Europe Antibody Testing Sales, by Country K Unit (2017-2022)
  • Table 193. Europe Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 194. Europe Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 195. Europe Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 196. Europe Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 197. Germany Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 198. Germany Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 199. Germany Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 200. Germany Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 201. France Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 202. France Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 203. France Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 204. France Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 205. Italy Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 206. Italy Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 207. Italy Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 208. Italy Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 209. United Kingdom Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 210. United Kingdom Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 211. United Kingdom Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 212. United Kingdom Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 213. Netherlands Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 214. Netherlands Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 215. Netherlands Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 216. Netherlands Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 217. Rest of Europe Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 218. Rest of Europe Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 219. Rest of Europe Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 220. Rest of Europe Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 221. MEA Antibody Testing Sales, by Country K Unit (2017-2022)
  • Table 222. MEA Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 223. MEA Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 224. MEA Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 225. MEA Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 226. Middle East Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 227. Middle East Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 228. Middle East Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 229. Middle East Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 230. Africa Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 231. Africa Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 232. Africa Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 233. Africa Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 234. North America Antibody Testing Sales, by Country K Unit (2017-2022)
  • Table 235. North America Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 236. North America Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 237. North America Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 238. North America Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 239. United States Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 240. United States Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 241. United States Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 242. United States Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 243. Canada Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 244. Canada Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 245. Canada Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 246. Canada Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 247. Mexico Antibody Testing Sales, by Type K Unit (2017-2022)
  • Table 248. Mexico Antibody Testing Sales, by Application K Unit (2017-2022)
  • Table 249. Mexico Antibody Testing Sales, by Disease K Unit (2017-2022)
  • Table 250. Mexico Antibody Testing Sales, by Technique K Unit (2017-2022)
  • Table 251. Antibody Testing: by Type(USD/Units)
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Antibody Testing: by Type(USD Million)
  • Table 263. Antibody Testing Assay Kits & Reagents , by Region USD Million (2023-2028)
  • Table 264. Antibody Testing Software & Services , by Region USD Million (2023-2028)
  • Table 265. Antibody Testing: by Application(USD Million)
  • Table 266. Antibody Testing Hospitals , by Region USD Million (2023-2028)
  • Table 267. Antibody Testing Clinical Laboratories , by Region USD Million (2023-2028)
  • Table 268. Antibody Testing Test Centers , by Region USD Million (2023-2028)
  • Table 269. Antibody Testing: by Disease(USD Million)
  • Table 270. Antibody Testing Covid-19 , by Region USD Million (2023-2028)
  • Table 271. Antibody Testing Human Immunodeficiency Virus (HIV) , by Region USD Million (2023-2028)
  • Table 272. Antibody Testing Crest Syndrome , by Region USD Million (2023-2028)
  • Table 273. Antibody Testing Other , by Region USD Million (2023-2028)
  • Table 274. Antibody Testing: by Technique(USD Million)
  • Table 275. Antibody Testing Inova Diagnostics (United States) , by Region USD Million (2023-2028)
  • Table 276. Antibody Testing Zeus Scientific Inc. (United States) , by Region USD Million (2023-2028)
  • Table 277. Antibody Testing Ortho Clinical Diagnostics (Unites States) , by Region USD Million (2023-2028)
  • Table 278. South America Antibody Testing, by Country USD Million (2023-2028)
  • Table 279. South America Antibody Testing, by Type USD Million (2023-2028)
  • Table 280. South America Antibody Testing, by Application USD Million (2023-2028)
  • Table 281. South America Antibody Testing, by Disease USD Million (2023-2028)
  • Table 282. South America Antibody Testing, by Technique USD Million (2023-2028)
  • Table 283. Brazil Antibody Testing, by Type USD Million (2023-2028)
  • Table 284. Brazil Antibody Testing, by Application USD Million (2023-2028)
  • Table 285. Brazil Antibody Testing, by Disease USD Million (2023-2028)
  • Table 286. Brazil Antibody Testing, by Technique USD Million (2023-2028)
  • Table 287. Argentina Antibody Testing, by Type USD Million (2023-2028)
  • Table 288. Argentina Antibody Testing, by Application USD Million (2023-2028)
  • Table 289. Argentina Antibody Testing, by Disease USD Million (2023-2028)
  • Table 290. Argentina Antibody Testing, by Technique USD Million (2023-2028)
  • Table 291. Rest of South America Antibody Testing, by Type USD Million (2023-2028)
  • Table 292. Rest of South America Antibody Testing, by Application USD Million (2023-2028)
  • Table 293. Rest of South America Antibody Testing, by Disease USD Million (2023-2028)
  • Table 294. Rest of South America Antibody Testing, by Technique USD Million (2023-2028)
  • Table 295. Asia Pacific Antibody Testing, by Country USD Million (2023-2028)
  • Table 296. Asia Pacific Antibody Testing, by Type USD Million (2023-2028)
  • Table 297. Asia Pacific Antibody Testing, by Application USD Million (2023-2028)
  • Table 298. Asia Pacific Antibody Testing, by Disease USD Million (2023-2028)
  • Table 299. Asia Pacific Antibody Testing, by Technique USD Million (2023-2028)
  • Table 300. China Antibody Testing, by Type USD Million (2023-2028)
  • Table 301. China Antibody Testing, by Application USD Million (2023-2028)
  • Table 302. China Antibody Testing, by Disease USD Million (2023-2028)
  • Table 303. China Antibody Testing, by Technique USD Million (2023-2028)
  • Table 304. Japan Antibody Testing, by Type USD Million (2023-2028)
  • Table 305. Japan Antibody Testing, by Application USD Million (2023-2028)
  • Table 306. Japan Antibody Testing, by Disease USD Million (2023-2028)
  • Table 307. Japan Antibody Testing, by Technique USD Million (2023-2028)
  • Table 308. India Antibody Testing, by Type USD Million (2023-2028)
  • Table 309. India Antibody Testing, by Application USD Million (2023-2028)
  • Table 310. India Antibody Testing, by Disease USD Million (2023-2028)
  • Table 311. India Antibody Testing, by Technique USD Million (2023-2028)
  • Table 312. South Korea Antibody Testing, by Type USD Million (2023-2028)
  • Table 313. South Korea Antibody Testing, by Application USD Million (2023-2028)
  • Table 314. South Korea Antibody Testing, by Disease USD Million (2023-2028)
  • Table 315. South Korea Antibody Testing, by Technique USD Million (2023-2028)
  • Table 316. Taiwan Antibody Testing, by Type USD Million (2023-2028)
  • Table 317. Taiwan Antibody Testing, by Application USD Million (2023-2028)
  • Table 318. Taiwan Antibody Testing, by Disease USD Million (2023-2028)
  • Table 319. Taiwan Antibody Testing, by Technique USD Million (2023-2028)
  • Table 320. Australia Antibody Testing, by Type USD Million (2023-2028)
  • Table 321. Australia Antibody Testing, by Application USD Million (2023-2028)
  • Table 322. Australia Antibody Testing, by Disease USD Million (2023-2028)
  • Table 323. Australia Antibody Testing, by Technique USD Million (2023-2028)
  • Table 324. Rest of Asia-Pacific Antibody Testing, by Type USD Million (2023-2028)
  • Table 325. Rest of Asia-Pacific Antibody Testing, by Application USD Million (2023-2028)
  • Table 326. Rest of Asia-Pacific Antibody Testing, by Disease USD Million (2023-2028)
  • Table 327. Rest of Asia-Pacific Antibody Testing, by Technique USD Million (2023-2028)
  • Table 328. Europe Antibody Testing, by Country USD Million (2023-2028)
  • Table 329. Europe Antibody Testing, by Type USD Million (2023-2028)
  • Table 330. Europe Antibody Testing, by Application USD Million (2023-2028)
  • Table 331. Europe Antibody Testing, by Disease USD Million (2023-2028)
  • Table 332. Europe Antibody Testing, by Technique USD Million (2023-2028)
  • Table 333. Germany Antibody Testing, by Type USD Million (2023-2028)
  • Table 334. Germany Antibody Testing, by Application USD Million (2023-2028)
  • Table 335. Germany Antibody Testing, by Disease USD Million (2023-2028)
  • Table 336. Germany Antibody Testing, by Technique USD Million (2023-2028)
  • Table 337. France Antibody Testing, by Type USD Million (2023-2028)
  • Table 338. France Antibody Testing, by Application USD Million (2023-2028)
  • Table 339. France Antibody Testing, by Disease USD Million (2023-2028)
  • Table 340. France Antibody Testing, by Technique USD Million (2023-2028)
  • Table 341. Italy Antibody Testing, by Type USD Million (2023-2028)
  • Table 342. Italy Antibody Testing, by Application USD Million (2023-2028)
  • Table 343. Italy Antibody Testing, by Disease USD Million (2023-2028)
  • Table 344. Italy Antibody Testing, by Technique USD Million (2023-2028)
  • Table 345. United Kingdom Antibody Testing, by Type USD Million (2023-2028)
  • Table 346. United Kingdom Antibody Testing, by Application USD Million (2023-2028)
  • Table 347. United Kingdom Antibody Testing, by Disease USD Million (2023-2028)
  • Table 348. United Kingdom Antibody Testing, by Technique USD Million (2023-2028)
  • Table 349. Netherlands Antibody Testing, by Type USD Million (2023-2028)
  • Table 350. Netherlands Antibody Testing, by Application USD Million (2023-2028)
  • Table 351. Netherlands Antibody Testing, by Disease USD Million (2023-2028)
  • Table 352. Netherlands Antibody Testing, by Technique USD Million (2023-2028)
  • Table 353. Rest of Europe Antibody Testing, by Type USD Million (2023-2028)
  • Table 354. Rest of Europe Antibody Testing, by Application USD Million (2023-2028)
  • Table 355. Rest of Europe Antibody Testing, by Disease USD Million (2023-2028)
  • Table 356. Rest of Europe Antibody Testing, by Technique USD Million (2023-2028)
  • Table 357. MEA Antibody Testing, by Country USD Million (2023-2028)
  • Table 358. MEA Antibody Testing, by Type USD Million (2023-2028)
  • Table 359. MEA Antibody Testing, by Application USD Million (2023-2028)
  • Table 360. MEA Antibody Testing, by Disease USD Million (2023-2028)
  • Table 361. MEA Antibody Testing, by Technique USD Million (2023-2028)
  • Table 362. Middle East Antibody Testing, by Type USD Million (2023-2028)
  • Table 363. Middle East Antibody Testing, by Application USD Million (2023-2028)
  • Table 364. Middle East Antibody Testing, by Disease USD Million (2023-2028)
  • Table 365. Middle East Antibody Testing, by Technique USD Million (2023-2028)
  • Table 366. Africa Antibody Testing, by Type USD Million (2023-2028)
  • Table 367. Africa Antibody Testing, by Application USD Million (2023-2028)
  • Table 368. Africa Antibody Testing, by Disease USD Million (2023-2028)
  • Table 369. Africa Antibody Testing, by Technique USD Million (2023-2028)
  • Table 370. North America Antibody Testing, by Country USD Million (2023-2028)
  • Table 371. North America Antibody Testing, by Type USD Million (2023-2028)
  • Table 372. North America Antibody Testing, by Application USD Million (2023-2028)
  • Table 373. North America Antibody Testing, by Disease USD Million (2023-2028)
  • Table 374. North America Antibody Testing, by Technique USD Million (2023-2028)
  • Table 375. United States Antibody Testing, by Type USD Million (2023-2028)
  • Table 376. United States Antibody Testing, by Application USD Million (2023-2028)
  • Table 377. United States Antibody Testing, by Disease USD Million (2023-2028)
  • Table 378. United States Antibody Testing, by Technique USD Million (2023-2028)
  • Table 379. Canada Antibody Testing, by Type USD Million (2023-2028)
  • Table 380. Canada Antibody Testing, by Application USD Million (2023-2028)
  • Table 381. Canada Antibody Testing, by Disease USD Million (2023-2028)
  • Table 382. Canada Antibody Testing, by Technique USD Million (2023-2028)
  • Table 383. Mexico Antibody Testing, by Type USD Million (2023-2028)
  • Table 384. Mexico Antibody Testing, by Application USD Million (2023-2028)
  • Table 385. Mexico Antibody Testing, by Disease USD Million (2023-2028)
  • Table 386. Mexico Antibody Testing, by Technique USD Million (2023-2028)
  • Table 387. Antibody Testing Sales: by Type(K Unit)
  • Table 388. Antibody Testing Sales Assay Kits & Reagents , by Region K Unit (2023-2028)
  • Table 389. Antibody Testing Sales Software & Services , by Region K Unit (2023-2028)
  • Table 390. Antibody Testing Sales: by Application(K Unit)
  • Table 391. Antibody Testing Sales Hospitals , by Region K Unit (2023-2028)
  • Table 392. Antibody Testing Sales Clinical Laboratories , by Region K Unit (2023-2028)
  • Table 393. Antibody Testing Sales Test Centers , by Region K Unit (2023-2028)
  • Table 394. Antibody Testing Sales: by Disease(K Unit)
  • Table 395. Antibody Testing Sales Covid-19 , by Region K Unit (2023-2028)
  • Table 396. Antibody Testing Sales Human Immunodeficiency Virus (HIV) , by Region K Unit (2023-2028)
  • Table 397. Antibody Testing Sales Crest Syndrome , by Region K Unit (2023-2028)
  • Table 398. Antibody Testing Sales Other , by Region K Unit (2023-2028)
  • Table 399. Antibody Testing Sales: by Technique(K Unit)
  • Table 400. Antibody Testing Sales Inova Diagnostics (United States) , by Region K Unit (2023-2028)
  • Table 401. Antibody Testing Sales Zeus Scientific Inc. (United States) , by Region K Unit (2023-2028)
  • Table 402. Antibody Testing Sales Ortho Clinical Diagnostics (Unites States) , by Region K Unit (2023-2028)
  • Table 403. South America Antibody Testing Sales, by Country K Unit (2023-2028)
  • Table 404. South America Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 405. South America Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 406. South America Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 407. South America Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 408. Brazil Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 409. Brazil Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 410. Brazil Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 411. Brazil Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 412. Argentina Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 413. Argentina Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 414. Argentina Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 415. Argentina Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 416. Rest of South America Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 417. Rest of South America Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 418. Rest of South America Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 419. Rest of South America Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 420. Asia Pacific Antibody Testing Sales, by Country K Unit (2023-2028)
  • Table 421. Asia Pacific Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 422. Asia Pacific Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 423. Asia Pacific Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 424. Asia Pacific Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 425. China Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 426. China Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 427. China Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 428. China Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 429. Japan Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 430. Japan Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 431. Japan Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 432. Japan Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 433. India Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 434. India Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 435. India Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 436. India Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 437. South Korea Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 438. South Korea Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 439. South Korea Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 440. South Korea Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 441. Taiwan Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 442. Taiwan Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 443. Taiwan Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 444. Taiwan Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 445. Australia Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 446. Australia Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 447. Australia Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 448. Australia Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 449. Rest of Asia-Pacific Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 450. Rest of Asia-Pacific Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 451. Rest of Asia-Pacific Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 452. Rest of Asia-Pacific Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 453. Europe Antibody Testing Sales, by Country K Unit (2023-2028)
  • Table 454. Europe Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 455. Europe Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 456. Europe Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 457. Europe Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 458. Germany Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 459. Germany Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 460. Germany Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 461. Germany Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 462. France Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 463. France Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 464. France Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 465. France Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 466. Italy Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 467. Italy Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 468. Italy Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 469. Italy Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 470. United Kingdom Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 471. United Kingdom Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 472. United Kingdom Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 473. United Kingdom Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 474. Netherlands Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 475. Netherlands Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 476. Netherlands Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 477. Netherlands Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 478. Rest of Europe Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 479. Rest of Europe Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 480. Rest of Europe Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 481. Rest of Europe Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 482. MEA Antibody Testing Sales, by Country K Unit (2023-2028)
  • Table 483. MEA Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 484. MEA Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 485. MEA Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 486. MEA Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 487. Middle East Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 488. Middle East Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 489. Middle East Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 490. Middle East Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 491. Africa Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 492. Africa Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 493. Africa Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 494. Africa Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 495. North America Antibody Testing Sales, by Country K Unit (2023-2028)
  • Table 496. North America Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 497. North America Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 498. North America Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 499. North America Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 500. United States Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 501. United States Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 502. United States Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 503. United States Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 504. Canada Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 505. Canada Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 506. Canada Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 507. Canada Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 508. Mexico Antibody Testing Sales, by Type K Unit (2023-2028)
  • Table 509. Mexico Antibody Testing Sales, by Application K Unit (2023-2028)
  • Table 510. Mexico Antibody Testing Sales, by Disease K Unit (2023-2028)
  • Table 511. Mexico Antibody Testing Sales, by Technique K Unit (2023-2028)
  • Table 512. Antibody Testing: by Type(USD/Units)
  • Table 513. Research Programs/Design for This Report
  • Table 514. Key Data Information from Secondary Sources
  • Table 515. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antibody Testing: by Type USD Million (2017-2022)
  • Figure 5. Global Antibody Testing: by Application USD Million (2017-2022)
  • Figure 6. Global Antibody Testing: by Disease USD Million (2017-2022)
  • Figure 7. Global Antibody Testing: by Technique USD Million (2017-2022)
  • Figure 8. South America Antibody Testing Share (%), by Country
  • Figure 9. Asia Pacific Antibody Testing Share (%), by Country
  • Figure 10. Europe Antibody Testing Share (%), by Country
  • Figure 11. MEA Antibody Testing Share (%), by Country
  • Figure 12. North America Antibody Testing Share (%), by Country
  • Figure 13. Global Antibody Testing: by Type K Unit (2017-2022)
  • Figure 14. Global Antibody Testing: by Application K Unit (2017-2022)
  • Figure 15. Global Antibody Testing: by Disease K Unit (2017-2022)
  • Figure 16. Global Antibody Testing: by Technique K Unit (2017-2022)
  • Figure 17. South America Antibody Testing Share (%), by Country
  • Figure 18. Asia Pacific Antibody Testing Share (%), by Country
  • Figure 19. Europe Antibody Testing Share (%), by Country
  • Figure 20. MEA Antibody Testing Share (%), by Country
  • Figure 21. North America Antibody Testing Share (%), by Country
  • Figure 22. Global Antibody Testing: by Type USD/Units (2017-2022)
  • Figure 23. Global Antibody Testing share by Players 2022 (%)
  • Figure 24. Global Antibody Testing share by Players (Top 3) 2022(%)
  • Figure 25. Global Antibody Testing share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Alere Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Alere Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Hoffmann La Roche Revenue, Net Income and Gross profit
  • Figure 30. Hoffmann La Roche Revenue: by Geography 2022
  • Figure 31. Abbott Laboratories Revenue, Net Income and Gross profit
  • Figure 32. Abbott Laboratories Revenue: by Geography 2022
  • Figure 33. Bio-Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Bio-Rad Laboratories Inc. (United States) Revenue: by Geography 2022
  • Figure 35. ERBA Diagnostics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. ERBA Diagnostics Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Trinity Biotech plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 38. Trinity Biotech plc (Ireland) Revenue: by Geography 2022
  • Figure 39. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2022
  • Figure 41. Antibodies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Antibodies Inc. (United States) Revenue: by Geography 2022
  • Figure 43. EUROIMMUN AG (Germany) Revenue, Net Income and Gross profit
  • Figure 44. EUROIMMUN AG (Germany) Revenue: by Geography 2022
  • Figure 45. Immuno Concepts (United States) Revenue, Net Income and Gross profit
  • Figure 46. Immuno Concepts (United States) Revenue: by Geography 2022
  • Figure 47. Global Antibody Testing: by Type USD Million (2023-2028)
  • Figure 48. Global Antibody Testing: by Application USD Million (2023-2028)
  • Figure 49. Global Antibody Testing: by Disease USD Million (2023-2028)
  • Figure 50. Global Antibody Testing: by Technique USD Million (2023-2028)
  • Figure 51. South America Antibody Testing Share (%), by Country
  • Figure 52. Asia Pacific Antibody Testing Share (%), by Country
  • Figure 53. Europe Antibody Testing Share (%), by Country
  • Figure 54. MEA Antibody Testing Share (%), by Country
  • Figure 55. North America Antibody Testing Share (%), by Country
  • Figure 56. Global Antibody Testing: by Type K Unit (2023-2028)
  • Figure 57. Global Antibody Testing: by Application K Unit (2023-2028)
  • Figure 58. Global Antibody Testing: by Disease K Unit (2023-2028)
  • Figure 59. Global Antibody Testing: by Technique K Unit (2023-2028)
  • Figure 60. South America Antibody Testing Share (%), by Country
  • Figure 61. Asia Pacific Antibody Testing Share (%), by Country
  • Figure 62. Europe Antibody Testing Share (%), by Country
  • Figure 63. MEA Antibody Testing Share (%), by Country
  • Figure 64. North America Antibody Testing Share (%), by Country
  • Figure 65. Global Antibody Testing: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Alere Inc. (United States)
  • Hoffmann La Roche
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc. (United States)
  • ERBA Diagnostics Inc. (United States)
  • Trinity Biotech plc (Ireland)
  • Thermo Fisher Scientific Inc. (United States)
  • Antibodies Inc. (United States)
  • EUROIMMUN AG (Germany)
  • Immuno Concepts (United States)
Additional players considered in the study are as follows:
Inova Diagnostics (United States) , Zeus Scientific Inc. (United States) , Ortho Clinical Diagnostics (Unites States)
Select User Access Type

Key Highlights of Report


Jun 2023 209 Pages 78 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antibody Testing Market Quantitative research analysis
Global Antibody Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Antibody Testing Market are by type [Assay Kits & Reagents and Software & Services], by end use application [Hospitals, Clinical Laboratories and Test Centers].
The Antibody Testing Market is gaining popularity and expected to see strong valuation by 2028.
  • Prevalence of SARS-CoV-2 Cases
  • Emergence of Advance and Effective Techniques

Know More About Global Antibody Testing Market Report?

Have a Query? Click Here

Other Related Reports

Tissue Oximetry Devices Comprehensive Study by Type (Modular Devices, Handheld Devices), Application (Deep Hypothermic Circulatory Arrest, Coronary Artery Bypass Surgery, Carotid Endarterectomy, Card...
$ 3450
Wearable Tremor Therapy Comprehensive Study by Type (Wrist Mechatronic Systems, Orthotic Gloves), Distribution Channel (Online Dispensaries, Retail Pharmacies), Body Part (Elbow, Arms, Wrist), End Us...
$ 3350
Biomedical Warming and Thawing Devices Comprehensive Study by Type (Automatic, Manual), Application (Hospital, Laboratory, Research Institutions, Others), Sample (Blood Products, Ovum/Embryo, Semen) ...
$ 3500
Ophthalmic Perimeters Comprehensive Study by Type (Static, Kinetic, Combination), Function (Single Function, Multifunction), End-users (Hospital, Ophthalmic Clinic, Others) Players and Region - Globa...
$ 3500
Hemoglobin Testing Devices Comprehensive Study by Type (Bench-top, Handheld, Others), End-users (Hospitals, Clinics, Laboratories, Home Care Settings, Blood Banks), Technology (Chromatography, Immuno...
$ 3450
Pediatric And Adult Hemoconcentrators Comprehensive Study by Type (Pediatric Hemoconcentrators, Adult Hemoconcentrators), Application (Hospitals, Ambulatory Surgical Centre, Others) Players and Regio...
$ 3500